Cargando…
SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease and still continues to have the worst prognosis of all gastrointestinal malignancies. Reports have demonstrated that secretory leukocyte protease inhibitor (SLPI) is overexpressed in various cancers and may be a potential t...
Autores principales: | Zhang, Wei, Yao, Jian-Long, Dong, Shan-Chao, Hou, Feng-Qiang, Shi, He-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423143/ https://www.ncbi.nlm.nih.gov/pubmed/25954138 http://dx.doi.org/10.1186/s12935-015-0182-4 |
Ejemplares similares
-
MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma
por: Wang, Xing, et al.
Publicado: (2020) -
MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma
por: Dai, Chen, et al.
Publicado: (2020) -
Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression
por: Pan, Zongfu, et al.
Publicado: (2018) -
Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021) -
Human mast cells decrease SLPI levels in type II – like alveolar cell model, in vitro
por: Hollander, Camilla, et al.
Publicado: (2003)